About Klintoz Pharmaceuticals Private Limited
Data last updated:
Klintoz Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 July 2003 and has been in existence for over 23 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24239DL2003PTC121451. Its GSTIN is 05AACCK5302J1ZU (Uttarakhand). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹12 Cr and a paid-up capital of ₹10.38 Cr. It is led by directors including Amita Singh and Raj Kishor Singh.
Its last annual general meeting (AGM) was held on 14 August 2026, and its latest financial statements are for the year ended 31 March 2026. The registered office is at 405 Madhuban Bulding – 55 Nehru Place, New Delhi, Delhi, India – 110019.
As per the financials filed for FY 2026, the company reported a revenue of ₹1.14 Cr, a decline of 9% compared to the previous year. For the same year it recorded a net loss of ₹41.74 Lakh (net margin -36.7%) and EBITDA of -₹21.28 Lakh (EBITDA margin -18.7%).
The company has about 31 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Klintoz Pharmaceuticals. As per MCA filings, the company has satisfied charges of ₹5.95 Cr on record. Court records list 11 cases involving the company, including 6 filed by the company and 5 filed against it; 2 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website klintoz.com.
Company details
Contact details
Klintoz Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its website is klintoz.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address405 Madhuban Bulding – 55 Nehru Place, New Delhi, Delhi, India – 110019
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Klintoz Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Klintoz Pharmaceuticals operates one associated brand: Klintoz Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing and exporting of pharmaceutical formulations including generics and branded medicines. | klintoz.com |
Business activity
The main business activity of Klintoz Pharmaceuticals is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Klintoz Pharmaceuticals Private Limited, buy the company report.
Financials of Klintoz Pharmaceuticals Private Limited
FY 2026 filings availableKlintoz Pharmaceuticals Private Limited reported revenue of ₹1.14 Cr (down 9% YoY) for FY 2026.
Compounded Annual Growth Rate (CAGR)
Revenue fell 9% in the latest year. EBITDA rose 33% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹1.14 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹21.28 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹41.74 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -18.7% | ||||
| Net Profit Margin | -36.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Klintoz Pharmaceuticals Private Limited, buy the company report.
Board of directors of Klintoz Pharmaceuticals Private Limited
Klintoz Pharmaceuticals has 3 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amita Singh | Director | 02 Apr 2007 | 19 Years 7 Months | Current |
| Raj Kishor Singh | Director | 23 Jul 2003 | 23 Years 3 Months | Current |
| Aditya Vikram Roy Chowdhury | Director | 30 Mar 2024 | 2 Years 7 Months | Current |
Auditor
Klintoz Pharmaceuticals Private Limited is audited by Vinay Jalan & Associates for the financial year 2026.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Vinay Jalan & Associates | FY 2026 | 033589N |
Shareholding
The shareholding of Klintoz Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2026, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Klintoz Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 14 Feb 2007 | 10039252 | Punjab National Bank | ₹5.95 Cr | Satisfied |
To see the full charge records of Klintoz Pharmaceuticals Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
Klintoz Pharmaceuticals Private Limited has 11 court cases on record: 6 filed by Klintoz Pharmaceuticals, 5 filed against it. 2 cases are pending and 9 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 9 | 4 | 2 |
| High courts | 2 | 1 | 0 |
Cases on record (5 of 11)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South, Delhi | Interim or miscellaneous application | Filed against the company by an individual | Pending |
| District court, Patna, Bihar | Execution petition | Filed by the company against M/S Triveni Agency Through Proprietor | Pending |
| District court, Patna, Bihar | Execution petition | Filed by the company against M/S Sri Triveni Agency Through Its Proprieter Mr. Anand Kumar Agrawal | Disposed |
| District court, South, Delhi | Execution petition | Filed by the company against M/S Sri Treveni Agency | Disposed |
| District court, Patna, Bihar | Court case (Title Appeal) | Filed against the company by Indian Overseas Bank and Anothers | Disposed |
To see the full case history of Klintoz Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Klintoz Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Klintoz Pharmaceuticals Private Limited has a workforce of 31 employees on its EPFO records as of Apr 08, 2024, across 2 active EPFO establishments.
GST
Klintoz Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AACCK5302J1ZU | Uttarakhand | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Klintoz Pharmaceuticals Private Limited, buy the company report.
Recent activity
Klintoz Pharmaceuticals Private Limited has 10 board changes on record since 2003: 3 appointments and 7 cessations. The latest: Aditya Vikram Roy Chowdhury was appointed as Director on 30 Mar 2024.
3 earlier events are in the company report.
Frequently asked questions
Klintoz Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 23 July 2003 (23+ years old) and is registered under CIN U24239DL2003PTC121451.
Klintoz Pharmaceuticals has 3 current directors:
- Amita Singh - Director
- Raj Kishor Singh - Director
- Aditya Vikram Roy Chowdhury - Director
The latest financial statements of Klintoz Pharmaceuticals on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 14 August 2026. Year-wise statements from 2015 are in the company report.
The GSTIN of Klintoz Pharmaceuticals is 05AACCK5302J1ZU, registered in Uttarakhand. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Klintoz Pharmaceuticals is U24239DL2003PTC121451. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Klintoz Pharmaceuticals has 11 court cases on record: 6 filed by the company and 5 filed against it. 2 are pending. Most are in the district courts.
Klintoz Pharmaceuticals was incorporated on 23 July 2003, making it 23+ years old. It is registered with the Registrar of Companies, Delhi.
Aditya Vikram Roy Chowdhury was appointed as Director on 30 Mar 2024. Saurya Vikram Roychowdhury ceased to be Additional Director on 29 Mar 2024. Jaspinder Singh ceased to be Company Secretary on 10 Oct 2017. Klintoz Pharmaceuticals has 10 board changes on record in total.
Klintoz Pharmaceuticals can be reached through the website klintoz.com. Its registered office is in New Delhi, Delhi, India.
The registered office of Klintoz Pharmaceuticals is at 405 Madhuban Bulding – 55 Nehru Place, New Delhi, Delhi, India – 110019.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
